Genus Shares Fall 7% on Cautious FY27 Outlook

Genus shares dropped more than 7% despite reporting a 35% increase in annual adjusted profit, as the animal genetics group pointed to growing headwinds in North American pork production, Brazilian pork prices, and global dairy markets for fiscal 2027.

"Market conditions in FY27 appear more challenging, reflected in the c.3% growth outlook, while the lack of clarity around PRP key market timings is understandable but frustrating," said analysts at Stifel in a note to clients.

Annual Financial Performance and Buyback

For the financial year ended June 30, Genus reported an adjusted profit before tax of £100.2 million. This marked a 35% increase compared to £74.3 million recorded in the previous fiscal year.

Alongside the earnings report, management announced a new £60 million share buyback programme. Adjusted earnings per share also rose 35% to 110.3 pence, up from 81.8 pence a year earlier.

Despite the profit growth, group revenue fell 2% to £658.1 million. According to the earnings report, this top-line decline was primarily driven by the deconsolidation of PIC China.

"The £60 million buyback provides fair recognition of progress and the PIC China JV 'windfall,'" Stifel analysts added regarding the capital return.

Fiscal 2027 Headwinds and Second-Half Weighting

Looking ahead to fiscal 2027, Genus expects its adjusted profit before tax to be second-half weighted. The caution stems from several distinct agricultural and livestock market pressures.

• North American pork: Disease-related challenges impacting production efficiency.

• Brazilian pork: Depressed local market prices reducing margins.

• Global dairy: Subdued commodity and market prices affecting demand for genetic services.

What Is at Stake for Animal Genetics

Animal genetics companies rely on steady capital investment from farmers and breeding operations to fund long-term research and development in porcine and bovine breeding lines. When livestock producers face margin compression from disease outbreaks or low commodity prices, demand for premium breeding stock and advanced reproductive technologies often experiences friction, directly influencing valuation multiples across the sector.